Attachment for esophageal dilatatio
Phase 2
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-jRCTs052190063
- Lead Sponsor
- Ishihara Ryu
- Brief Summary
Primary outcome Success rate was 90.5% Secondary outcome No adverse event.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
1) Esophageal stricture after esophageal endoscopic treatment. Patients have stricture symptom (Dysphagia score of 2 or more).
2) Strictures are located in thoracic and/or abdominal esophagus.
3) No organ failure
4) 20 years or more, 90 years old or less
5) Written informed consent had been obtained
Exclusion Criteria
1) Stricture is derived from esophageal cancer itself and chemoradiotherapy.
2) Ulcer after endoscopic treatment.
3) Cancers in other organs with life expectancy of three months or less
4) Severe stricture less than 6mm
5) Inadequate case judged by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success rate of esophageal dilatation
- Secondary Outcome Measures
Name Time Method Adverse events.<br>Features of successful and unsuccessful cases.